EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - FRA:EWL - US28176E1082 - Common Stock
67.12 EUR
+1.92 (+2.94%)
We assign a fundamental rating of 7 out of 10 to EWL. EWL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, EWL is valued expensive at the moment. This makes EWL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
EWL had positive earnings in the past year.
In the past year EWL had a positive cash flow from operations.
Each year in the past 5 years EWL has been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
EWL's Return On Assets of 30.75% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
EWL has a better Return On Equity (39.33%) than 98.31% of its industry peers.
EWL has a Return On Invested Capital of 9.25%. This is in the better half of the industry: EWL outperforms 74.58% of its industry peers.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 9.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROIC | 9.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
With an excellent Profit Margin value of 72.96%, EWL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of EWL has grown nicely.
With an excellent Operating Margin value of 27.94%, EWL belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.
EWL's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 78.87%, EWL belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
Compared to 1 year ago, EWL has less shares outstanding
EWL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for EWL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 12.02 indicates that EWL is not in any danger for bankruptcy at the moment.
EWL has a Altman-Z score of 12.02. This is amongst the best in the industry. EWL outperforms 94.92% of its industry peers.
The Debt to FCF ratio of EWL is 1.03, which is an excellent value as it means it would take EWL, only 1.03 years of fcf income to pay off all of its debts.
EWL's Debt to FCF ratio of 1.03 is amongst the best of the industry. EWL outperforms 84.75% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Altman-Z | 12.02 |
ROIC/WACC1.08
WACC8.53%
2.3 Liquidity
A Current Ratio of 4.68 indicates that EWL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.68, EWL belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
EWL has a Quick Ratio of 3.87. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.87, EWL belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.77%.
Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
EWL shows a decrease in Revenue. In the last year, the revenue decreased by -1.09%.
Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
3.2 Future
EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.38% yearly.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.39% on average per year.
EPS Next Y-1.75%
EPS Next 2Y4.72%
EPS Next 3Y7.26%
EPS Next 5Y9.38%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.39%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 30.23, which means the current valuation is very expensive for EWL.
EWL's Price/Earnings ratio is in line with the industry average.
EWL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.57.
The Price/Forward Earnings ratio is 27.07, which means the current valuation is very expensive for EWL.
EWL's Price/Forward Earnings ratio is in line with the industry average.
EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.09.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.23 | ||
| Fwd PE | 27.07 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA is on the same level as the industry average.
EWL's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 79.01 | ||
| EV/EBITDA | 23.79 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.24
EPS Next 2Y4.72%
EPS Next 3Y7.26%
5. Dividend
5.1 Amount
EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (10/22/2025, 7:00:00 PM)
67.12
+1.92 (+2.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap39.41B
Revenue(TTM)5.69B
Net Income(TTM)4.15B
Analysts76.28
Price Target76.64 (14.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)1.3%
PT rev (3m)5.52%
EPS NQ rev (1m)0.67%
EPS NQ rev (3m)-0.98%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.23 | ||
| Fwd PE | 27.07 | ||
| P/S | 8.03 | ||
| P/FCF | 79.01 | ||
| P/OCF | 57.44 | ||
| P/B | 4.33 | ||
| P/tB | 6.01 | ||
| EV/EBITDA | 23.79 |
EPS(TTM)2.22
EY3.31%
EPS(NY)2.48
Fwd EY3.69%
FCF(TTM)0.85
FCFY1.27%
OCF(TTM)1.17
OCFY1.74%
SpS8.36
BVpS15.5
TBVpS11.17
PEG (NY)N/A
PEG (5Y)4.24
Graham Number27.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROCE | 13.14% | ||
| ROIC | 9.25% | ||
| ROICexc | 13.94% | ||
| ROICexgc | 22.05% | ||
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% | ||
| FCFM | 10.17% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 142.95% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.68% | ||
| Profit Quality | 13.93% | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 12.02 |
F-Score7
WACC8.53%
ROIC/WACC1.08
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
EPS Next Y-1.75%
EPS Next 2Y4.72%
EPS Next 3Y7.26%
EPS Next 5Y9.38%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.39%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.05%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%